Literature DB >> 16601719

Putting pharmacogenetics into practice.

Michael M Hopkins1, Dolores Ibarreta, Sibylle Gaisser, Christien M Enzing, Jim Ryan, Paul A Martin, Graham Lewis, Symone Detmar, M Elske van den Akker-van Marle, Adam M Hedgecoe, Paul Nightingale, Marieke Dreiling, K Juliane Hartig, Wieneke Vullings, Tony Forde.   

Abstract

Genetics is slowly explaining variations in drug response, but applying this knowledge depends on implementation of a host of policies that provide long-term support to the field, from translational research and regulation to professional education.

Mesh:

Year:  2006        PMID: 16601719     DOI: 10.1038/nbt0406-403

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


  16 in total

1.  Delivering a pharmacogenetic service: is there a role for genetic counselors?

Authors:  Alice Callard; William Newman; Katherine Payne
Journal:  J Genet Couns       Date:  2011-11-04       Impact factor: 2.537

2.  Biomarker patents for diagnostics: problem or solution?

Authors:  Michael M Hopkins; Stuart Hogarth
Journal:  Nat Biotechnol       Date:  2012-06-07       Impact factor: 54.908

3.  Translational integrity and continuity: personalized biomedical data integration.

Authors:  Xiaoming Wang; Lili Liu; James Fackenthal; Shelly Cummings; Maggie Cook; Kisha Hope; Jonathan C Silverstein; Olufunmilayo I Olopade
Journal:  J Biomed Inform       Date:  2008-08-12       Impact factor: 6.317

Review 4.  Pharmacogenomics of CYP3A: considerations for HIV treatment.

Authors:  Sukhwinder S Lakhman; Qing Ma; Gene D Morse
Journal:  Pharmacogenomics       Date:  2009-08       Impact factor: 2.533

Review 5.  The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?

Authors:  Mafalda M Dias; Michael J Sorich; Andrew Rowland; Michael D Wiese; Ross A McKinnon
Journal:  Pharm Res       Date:  2017-02-24       Impact factor: 4.200

Review 6.  Attitudes of health care professionals toward pharmacogenetic testing.

Authors:  Nathalie K Zgheib; Thalia Arawi; Rami A Mahfouz; Ramzi Sabra
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

7.  A surveillance tool to support quality assurance and research in personalized medicine.

Authors:  Naqi A Khan; Josh F Peterson
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

8.  Risk assessment and communication tools for genotype associations with multifactorial phenotypes: the concept of "edge effect" and cultivating an ethical bridge between omics innovations and society.

Authors:  Vural Ozdemir; Guilherme Suarez-Kurtz; Raphaëlle Stenne; Andrew A Somogyi; Toshiyuki Someya; S Oğuz Kayaalp; Eugene Kolker
Journal:  OMICS       Date:  2009-02

9.  A Global Health Diagnostic for Personalized Medicine in Resource-Constrained World Settings: A Simple PCR-RFLP Method for Genotyping CYP2B6 g.15582C>T and Science and Policy Relevance for Optimal Use of Antiretroviral Drug Efavirenz.

Authors:  Jonathan Evans; Marelize Swart; Nyarai Soko; Ambroise Wonkam; Farah Huzair; Collet Dandara
Journal:  OMICS       Date:  2015-06

Review 10.  Chronic heart failure: beta-blockers and pharmacogenetics.

Authors:  Junichi Azuma; Shinpei Nonen
Journal:  Eur J Clin Pharmacol       Date:  2008-10-07       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.